hypericin has been researched along with 2019 Novel Coronavirus Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashyap, D | 1 |
| Roy, R | 1 |
| Kar, P | 1 |
| Jha, HC | 1 |
| Murali, M | 2 |
| Gowtham, HG | 2 |
| Shilpa, N | 2 |
| Krishnappa, HKN | 2 |
| Ledesma, AE | 2 |
| Jain, AS | 2 |
| Shati, AA | 2 |
| Alfaifi, MY | 2 |
| Elbehairi, SEI | 2 |
| Achar, RR | 2 |
| Silina, E | 2 |
| Stupin, V | 2 |
| Ortega-Castro, J | 2 |
| Frau, J | 2 |
| Flores-Holguín, N | 2 |
| Amruthesh, KN | 2 |
| Shivamallu, C | 2 |
| Kollur, SP | 2 |
| Glossman-Mitnik, D | 2 |
| Romeo, A | 1 |
| Iacovelli, F | 1 |
| Falconi, M | 1 |
| Pitsillou, E | 1 |
| Liang, J | 1 |
| Ververis, K | 1 |
| Hung, A | 1 |
| Karagiannis, TC | 1 |
4 other studies available for hypericin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an
Topics: Antiviral Agents; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Nuc | 2023 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Topics: Coronavirus 3C Proteases; COVID-19; Humans; Molecular Docking Simulation; Molecular Dynamics Simulat | 2022 |
Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
Topics: Anthracenes; Antiviral Agents; Betacoronavirus; Binding Sites; Coronavirus Infections; COVID-19; Gen | 2020 |
Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
Topics: Anthocyanins; Anthracenes; Antiviral Agents; Binding Sites; Coronavirus 3C Proteases; COVID-19; COVI | 2021 |